Glytec Unveils Real-Time Analytics to Help Hospitals Prepare for New CMS Measures –

Glytec Unveils Real-Time Analytics to Help Hospitals Prepare for New CMS Measures -


What You Should Know:

  • Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced the next evolution of GlucoMetricsⓇ to provide new analytics, dashboards and data visualizations that give hospitals and health systems new insight into glycemic outcomes. The enhanced visibility this provides is essential as hospitals prepare for new measures from the Centers for Medicare and Medicaid Services (CMS) on severe hypoglycemia and hyperglycemia that encourage facilities to report metrics starting in early 2024.
  • GlucoMetrics is powered by data from Glytec’s eGlycemic Management System® (eGMS). Centered on Glucommander,Ⓡ eGMS is an EHR-integrated, HITRUST certified, cloud-based software solution that supports personalized insulin dosing decision support at the point of care. Providers and nurses who use Glucommander help their patients get into target range faster, stay within tighter parameters and experience fewer insulin-related adverse drug events than patients treated with other protocols.
  • With significant enhancements to GlucoMetrics, glycemic management committees and hospital leaders now have self-serve access to key performance indicators, trends, and benchmarks related to glycemia treatment across their entire health system. GlucoMetrics is pre-configured with six interactive dashboards to help surface insights at both a macro and micro level.
  • These dashboards include powerful filters to segment data by time frame, facility, unit, treatment type (IV or subcutaneous) and more, to provide granular details across an entire healthcare system or down to an individual hospital unit level. Users can also customize their experience with saved views and personalized email subscriptions. In addition, they can easily export charts, tables, graphs, and data to Microsoft Excel or PowerPoint for even more sophisticated analysis, further annotations, or distribution.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *